Activation and evasion of antiviral innate immunity by hepatitis C virus.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Molecular Biology

• Publication date

  2014-03-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jmb.2013.10.032PMID 24184198PMCID PMC4431647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1

  2013cited by this paper
• Hepatitis C Virus Induces Interleukin-1β (IL-1β)/IL-18 in Circulatory and Resident Liver Macrophages

  2013cited by this paper
• Activation and regulation of the inflammasomes

  2013cited by this paper
• Understanding the hepatitis C virus life cycle paves the way for highly effective therapies

  2013cited by this paper
• Class A Scavenger Receptor 1 (MSR1) Restricts Hepatitis C Virus Replication by Mediating Toll-like Receptor 3 Recognition of Viral RNAs Produced in Neighboring Cells

  2013cited by this paper
• Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells

  2013cited by this paper
• Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.

  2013cited by this paper
• Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

  2013cited by this paper
• Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource

  2013cited by this paper
• Regulation of hepatic innate immunity by hepatitis C virus

  2013cited by this paper
• Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

  2013cited by this paper
• Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon‐λ in response to hepatitis C virus

  2013cited by this paper
• IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

  2013cited by this paper
• A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.

  2013cited by this paper
• Interferon-stimulated genes and their role in controlling hepatitis C virus.

  2013cited by this paper
• IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease

  2013cited by this paper
• A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

  2013cited by this paper
• Hepatitis C Virus Infection Induces Inflammatory Cytokines and Chemokines Mediated by the Cross Talk between Hepatocytes and Stellate Cells

  2013cited by this paper
• Current progress in development of hepatitis C virus vaccines

  2013cited by this paper
• Targeting the viral Achilles’ heel: recognition of 5′-triphosphate RNA in innate anti-viral defence

  2013cited by this paper
• Activation of chemokine and inflammatory cytokine response in hepatitis C virus–infected hepatocytes depends on toll‐like receptor 3 sensing of hepatitis C virus double‐stranded RNA intermediates

  2012influential reference
• Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33.

  2012cited by this paper
• The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity.

  2012cited by this paper
• MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells

  2012cited by this paper
• IL‐29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

  2012cited by this paper
• Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses

  2012cited by this paper
• Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex.

  2012cited by this paper
• Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.

  2012cited by this paper
• Convergent Evolution of Escape from Hepaciviral Antagonism in Primates

  2012cited by this paper
• Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.

  2012cited by this paper
• Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING

  2012cited by this paper
• HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.

  2012cited by this paper
• Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.

  2012cited by this paper
• Uridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-I

  2012cited by this paper
• Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.

  2012cited by this paper
• IFITM1 is a tight junction protein that inhibits hepatitis C virus entry†, ‡

  2012cited by this paper
• Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex

  2012cited by this paper
• Hepatitis C virus host cell entry.

  2012cited by this paper
• Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication

  2012cited by this paper
• Antiviral strategies in hepatitis C virus infection.

  2012cited by this paper
• A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.

  2012cited by this paper
• Membrane Perturbation Elicits an IRF3-Dependent, Interferon-Independent Antiviral Response

  2011cited by this paper
• Structural insights into RNA recognition by RIG-I.

  2011cited by this paper
• Interferon lambdas: the next cytokine storm

  2011cited by this paper
• Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA.

  2011cited by this paper
• A role for mitochondria in NLRP3 inflammasome activation

  2011cited by this paper
• Structural basis of RNA recognition and activation by innate immune receptor RIG-I

  2011cited by this paper
• A diverse array of gene products are effectors of the type I interferon antiviral response

  2011cited by this paper
• The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A

  2011cited by this paper
• Assembly of infectious hepatitis C virus particles.

  2011cited by this paper
• Viral Double-Strand RNA-Binding Proteins Can Enhance Innate Immune Signaling by Toll-Like Receptor 3

  2011cited by this paper
• High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection.

  2011cited by this paper
• Expression of Paramyxovirus V Proteins Promotes Replication and Spread of Hepatitis C Virus in Cultures of Primary Human Fetal Liver Cells

  2011cited by this paper
• Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response

  2011cited by this paper
• Intracellular sensing of microbes and danger signals by the inflammasomes

  2011cited by this paper
• Interferon-stimulated genes and their antiviral effector functions

  2011cited by this paper
• Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

  2011cited by this paper
• Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus

  2011cited by this paper
• Molecular Mechanism of Signal Perception and Integration by the Innate Immune Sensor Retinoic Acid-inducible Gene-I (RIG-I)*

  2011cited by this paper
• A new standard of care for the treatment of chronic HCV infection

  2011cited by this paper
• Interferon-lambda serum levels in hepatitis C.

  2011cited by this paper
• Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex

  2011cited by this paper
• Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus

  2011cited by this paper
• DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells.

  2011cited by this paper
• Immune signaling by RIG-I-like receptors.

  2011cited by this paper
• Hepatitis C virus induces interferon‐λ and interferon‐stimulated genes in primary liver cultures

  2011cited by this paper
• Adaptive immunity to the hepatitis C virus.

  2010cited by this paper
• Recognition of viruses by cytoplasmic sensors.

  2010cited by this paper
• Plasmacytoid dendritic cells sense hepatitis C virus–infected cells, produce interferon, and inhibit infection

  2010cited by this paper
• The Chase for the RIG-I Ligand-Recent Advances.

  2010cited by this paper
• Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients

  2010cited by this paper
• Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system

  2010cited by this paper
• Influenza virus activates inflammasomes through intracellular M2 channel

  2010cited by this paper
• The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain.

  2010cited by this paper
• Peroxisomes are signaling platforms for antiviral innate immunity.

  2010cited by this paper
• The chase for the RIG-I ligand--recent advances.

  2010cited by this paper
• Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing

  2010cited by this paper
• RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

  2010cited by this paper
• Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection.

  2010cited by this paper
• Regulation of Adaptive Immunity by the Innate Immune System

  2010cited by this paper
• Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

  2010cited by this paper
• Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

  2010cited by this paper
• Hepatitis C Virus Controls Interferon Production through PKR Activation

  2010cited by this paper
• RIGorous Detection: Exposing Virus Through RNA Sensing

  2010cited by this paper
• Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

  2009cited by this paper
• The autophagy machinery is required to initiate hepatitis C virus replication

  2009cited by this paper
• Nucleotide Sequences and Modifications That Determine RIG-I/RNA Binding and Signaling Activities

  2009cited by this paper
• New therapies for hepatitis C virus infection.

  2009cited by this paper
• Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy

  2009cited by this paper
• The global burden of hepatitis C

  2009cited by this paper
• Translational insensitivity to potent activation of PKR by HCV IRES RNA.

  2009cited by this paper
• The RNA-activated Protein Kinase Enhances the Induction of Interferon-β and Apoptosis Mediated by Cytoplasmic RNA Sensors*

  2009cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Nomenclature and numbering of the hepatitis C virus.

  2009cited by this paper
• Intracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus

  2009cited by this paper
• Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection

  2009cited by this paper
• IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

  2009cited by this paper
• Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

  2009cited by this paper

• Viroporins Manipulate Cellular Powerhouses and Modulate Innate Immunity

  2024cites this paper
• Genome-Wide Analysis of Differentially Expressed mRNAs and lncRNAs in Koi Carp Infected with Koi Herpesvirus

  2022cites this paper
• Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches

  2022cites this paper
• Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America

  2022cites this paper
• Microbes and Infectious Diseases Impact of Sofosbuvir and Daclatasvir therapy on the expression levels of inflammasomes in chronic hepatitis C infected patients

  2022cites this paper
• Features of Lipid Metabolism in HCV Infection

  2021cites this paper
• Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β

  2021cites this paper
• Differential expression of viral pathogen-associated molecular pattern receptors mRNA in Egyptian chronic hepatitis C virus patients

  2021cites this paper
• Comparative analysis of marine and freshwater viral haemorrhagic septicaemia virus (VHSV) isolates antagonistic activity.

  2020cites this paper
• Viroporins and inflammasomes: A key to understand virus-induced inflammation

  2020cites this paper
• Differential metabolism-associated gene expression of duck pancreatic cells in response to two strains of duck hepatitis A virus type 1

  2020cites this paper
• THE COVID-19 Pandemic

  2020cites this paper
• Effect of P‐body component Mov10 on HCV virus production and infectivity

  2020cites this paper
• Targeting viperin to the mitochondrion inhibits the thiolase activity of the trifunctional enzyme complex

  2019cites this paper
• Innate and Adaptive Immune Responses in Chronic Hepatitis C Virus and Hepatitis B Virus Infection with High Viral Loads

  2019cites this paper
• Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.

  2019cites this paper
• Hepatitis C Virus and Innate Interferon Response: Pathogen Biology, Drug Resistance, Novel Drug Targets, and Therapeutic Strategies

  2019cites this paper
• Transcriptome analysis of PK-15 cells in innate immune response to porcine deltacoronavirus infection

  2019cites this paper
• Antiviral Response by Plasmacytoid Dendritic Cells via Interferogenic Synapse with Infected Cells

  2018cites this paper
• Liver micro-RNAs and their role in different HCV genotype infections

  2018cites this paper
• HCV prevalence in the volunteer blood donors in Peshawar, Khyber Pakhtunkhwa

  2018cites this paper
• Replicase-mediated shielding of the poliovirus replicative double-stranded RNA to avoid recognition by MDA5.

  2018cites this paper
• On taking the STING out of immune activation

  2018cites this paper
• The role of IDO, IL‐10, and TGF‐β in the HCV‐associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

  2018cites this paper
• Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.

  2018cites this paper
• Immune responses in hepatitis B and C virus infection

  2017cites this paper
• HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation

  2017cites this paper
• Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy

  2017cites this paper
• Correlates of Long-term Immune Protection in Hepatitis C Virus (HCV) Exposed Non-reinfected Individuals

  2017cites this paper
• Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice.

  2016cites this paper
• Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers

  2016cites this paper
• Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection

  2016cites this paper
• HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses

  2016cites this paper
• HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2

  2016cites this paper
• Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection

  2016cites this paper
• Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson’s Disease

  2016influential citation
• Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C

  2016cites this paper
• Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5.

  2016cites this paper
• Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C

  2016cites this paper
• ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway

  2016cites this paper
• Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.

  2016cites this paper
• 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph.

  2016cites this paper
• The nuclear pore complex and its transporters : from virus-host interactors to subverting the innate antiviral immunity

  2016influential citation
• Inhibition of the host 5'-3' RNA decay pathway is a novel mechanism by which flaviviruses influence cellular gene expression

  2016cites this paper
• Recognition of hepatitis C virus RNA by toll like receptors 7 and 8 : implications for the initiation of innate immune response

  2015cites this paper
• The role of HCV proteins on treatment outcomes

  2015cites this paper
• Innate immune recognition of hepatitis B virus.

  2015cites this paper
• Early IFN type I response: Learning from microbial evasion strategies

  2015cites this paper
• RIG-I in RNA virus recognition

  2015cites this paper
• Liver-Resident CD103+ Dendritic Cells Prime Antiviral CD8+ T Cells In Situ

  2015cites this paper
• A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay.

  2015cites this paper
• Cellular stress responses in hepatitis C virus infection: Mastering a two-edged sword.

  2015cites this paper
• Activation of Type I and Type III Interferons in Chronic Hepatitis C

  2015cites this paper
• Progress in the development of vaccines for hepatitis C virus infection.

  2015cites this paper
• Innate detection of hepatitis B and C virus and viral inhibition of the response

  2015cites this paper
• This information is current as T Cells In Situ + Prime Antiviral CD 8 Dendritic Cells + Liver-Resident CD 103

  2015cites this paper
• Enhancement of the immune response by codelivery of hepatitis C virus recombinant DNA and proteins of the replicative complex

  2015cites this paper
• Proteomic Analysis of Mitochondrial-Associated ER Membranes (MAM) during RNA Virus Infection Reveals Dynamic Changes in Protein and Organelle Trafficking

  2015cites this paper
• Genetic and molecular technologies to optimise novel vaccines for Hepatitis C virus infection

  2015cites this paper
• Antiviral innate immunity: editorial overview.

  2014cites this paper
• Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis

  2014cites this paper
• Recognition of Human Oncogenic Viruses by Host Pattern-Recognition Receptors

  2014cites this paper
• Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses

  2014cites this paper
• Viral (HCV, HBV, HIV) Persistence and Immune Homeostasis

  2014cites this paper
• An overview of hepatitis C vaccines.

  2014cites this paper
• Hepatitis C virus infection: establishment of chronicity and liver disease progression

  2014cites this paper
• Innate immune cell networking in hepatitis C virus infection

  2014cites this paper
• Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection

  2014influential citation
• Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.

  2014cites this paper
• Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection

  2014cites this paper